Contineum Therapeutics, Inc. (CTNM) Operating income 2023–2025
Contineum Therapeutics, Inc. (CTNM) annual operating income history from SEC filings — each fiscal year as reported.
-$68.1MFY2025 · since FY2023: $16.1M → -$68.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$68.1M | -33.7% |
| FY2024 | -$50.9M | -416.6% |
| FY2023 | $16.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice